T44.5
Predominantly beta-adrenoreceptor agonists, not elsewhere classified
Coding guidance (WHO 2019)
Excl.: beta-adrenoreceptor agonists used in asthma therapy (T48.6)
Sibling codes
T44Poisoning by drugs primarily affecting the autonomic nervous systemT44.0Anticholinesterase agentsT44.1Other parasympathomimetics [cholinergics]T44.2Ganglionic blocking drugs, not elsewhere classifiedT44.3Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classifiedT44.4Predominantly alpha-adrenoreceptor agonists, not elsewhere classifiedT44.6Alpha-adrenoreceptor antagonists, not elsewhere classifiedT44.7Beta-adrenoreceptor antagonists, not elsewhere classifiedT44.8Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classifiedT44.9Other and unspecified drugs primarily affecting the autonomic nervous system